Cargando…
3H-3000, AN FGFR2B-SPECIFIC MONOCLONAL ANTIBODY, SHOWS SUPERIOR TUMOR KILLING IN VIVO
BACKGROUND AND SIGNIFICANCE: Fibroblast growth factor receptor 2b (FGFR2b), a splice isoform of FGFR2, is found to overexpress across multiple cancers types and promotes dysregulated tyrosine kinase activation, resulting in tumor cell proliferation and unchecked malignancy. Cohort studies reveal FGF...
Autores principales: | Li, You, Zhang, Jianwei, Wang, Ruiqin, Yin, Xueying, Liu, Susan, Lin, Jufang, Hu, Shaojing, Cai, Mingqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370428/ http://dx.doi.org/10.1093/abt/tbad014.016 |
Ejemplares similares
-
Fc-optimized monoclonal antibodies show superior efficacy
por: Flemming, Alexandra
Publicado: (2021) -
Monoclonal antibody‐mediated killing of tumour cells by neutrophils
por: Heemskerk, Niels, et al.
Publicado: (2018) -
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies
por: Storti, Paola, et al.
Publicado: (2020) -
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016) -
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
por: Goh, Angeline XH, et al.
Publicado: (2014)